Sulphonylurea binding in rat isolated glomeruli: Pharmacological characterization and dependence on cell metabolism and cytoskeleton

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 355, Issue 2, 1997, Pages 141-149

  Metzger, Friedrich ^a   Löffler, Cornelia ^a   Quast, Ulrich ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

3H glibenclamide binding; Cytoskeleton; Glomeruli; K(ATP) channels; Meglitinide; Sulphonylureas

Indexed keywords

4 [2 (3,4 DIHYDRO 7 METHOXY 4,4 DIMETHYL 1,3 DIOXO 2(1H) ISOQUINOLYL)ETHYL]BENZOIC ACID; 4 [[2 (1 PIPERIDYL)BENZHYDRYL]CARBAMOYLMETHYL]BENZOIC ACID; BENZOIC ACID DERIVATIVE; GLIBENCLAMIDE; GLIBORNURIDE; GLIPIZIDE; GLIQUIDONE; MEGLITINIDE; POTASSIUM CHANNEL; SULFONYLUREA; TOLBUTAMIDE; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOCHEMISTRY; DRUG RECEPTOR BINDING; GLOMERULUS; IN VITRO STUDY; MALE; METABOLIC INHIBITION; NONHUMAN; RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; BENZOATES; BINDING, COMPETITIVE; CYTOSKELETON; GLYBURIDE; KIDNEY GLOMERULUS; MALE; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, SPRAGUE-DAWLEY; SULFONYLUREA COMPOUNDS;

EID: 0031012405     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00004925     Document Type: Article

References (50)

1. +-channels. Cell Signals 2:197-214
2. Ashcroft SJH, Ashcroft FM (1992) The sulfonylurea receptor. Biochim Biophys Acta 1175:45-59
3. Bevington PR (1969) Data reduction and error analysis for the physical sciences. McGraw-Hill, New York, pp 55-65 and 92-118
4. + channel openers in rat aorta. J Biol Chem 267:11689-11692
5. Broillet MC, Horisberger JD (1993) Tolbutamide-sensitive potassium conductance in the basolateral membrane of A6 cells. J Membr Biol 134:181-188
6. Brown GR, Foubister AJ (1984) Receptor binding sites of hypoglycemic sulfonylureas and related [(acylamino)alkyl]benzoic acids. J Med Chem 27:79-81
7. Cooper JA (1987) Effects of cytochalasin and phalloidin on actin. J Cell Biol 105:1473-1478
8. 3H]P1075. FASEB J 7:A354
9. Draper NB, Smith H (1981) Applied regression analysis. Wiley, New York, pp 85-96 and 458-517
10. + channels. Annu Rev Pharmacol Toxicol 33:597-637
11. Ferrier CP, Kurtz A, Lehner P, Shaw SG, Pusterla C, Saxenhofer H, Weidmann P (1989) Stimulation of renin secretion by potassium-channel activation with cromakalim. Eur J Clin Pharmacol 36:443-447
12. + channels during metabolic stress in cardiac muscle. J Pharmacol Exp Ther 266:456-467
13. ATP channel as a receptor for potassium channel openers. J Biol Chem 271:8796-8799
14. Giebisch G (1993) Diuretic action of potassium channel blockers. Eur J Clin Pharmacol 44 [Suppl 1]: S3-S5
15. 3H]glyburide, to neuronal and muscle preparations. J Pharmacol Exp Ther 257:1162-1171
16. Guillemare E, Lazdunski M, Honoré E (1995) Glibenclamide opens ATP-sensitive potassium channels in xenopus oocyte follicular cells during metabolic stress. Mol Pharmacol 47:588-594
17. Hall SM, Haworth SG (1996) Effect of cold preservation on pulmonary arterial smooth muscle cells. Am J Physiol 270 (Lung Cell Mol Physiol 14):L435-L445
18. Hoffman Jr FJ, Lenfers JB, Niemers E, Pließ U, Scriabine A, Janis RA (1993) High affinity binding of a potassium channel agonist to intact rat insulinoma cells. Biochem Biophys Res Commun 190:551-558
19. + channels in the mitochondrial inner membrane. Nature 352:244-247
20. Koushanpour E, Kriz W (1986) Renal physiology: principal, structure, and function, 2nd edn. Springer, New York
21. Krause E, Englert H, Gögelein H (1995) Adenosine triphosphate-dependent K currents activated by metabolic inhibition in rat ventricular myocytes differ from those elicited by the channel opener rilmakalim. Pflügers Arch 429:625-635
22. Lemoine H, Mannhold R, Grittner D (1996) Binding studies with potassium channel openers (KCO) in smooth muscle cells of calf coronary artery as compared to rat cardiomyocytes. Naunyn-Schmiedeberg's Arch Pharmacol 353 [Suppl]:R54
23. 3H]-glipizide in rat cerebral cortex. Eur J Pharmacol 140:157-169
24. + channel blocker with diuretic/natriuretic properties. Mol Pharmacol 47:155-163
25. + channels, to rat glomerular preparations. Naunyn-Schmiedeberg's Arch Pharmacol 354: 452-459
26. Mills JW, Schwiebert EM, Stanton BA (1994) The cytoskeleton and membrane transport. Curr Opin Nephrol Hypertens 3:529-534
27. Misra RP (1972) Isolation of glomeruli from mammalian kidneys by graded sieving. Am J Clin Pathol 58:135-139
28. Niki I, Ashcroft SJH (1991) Possible involvement of protein phosphorylation in the regulation of the sulfonylurea receptor in a pancreatic β-cell line, HIT T15. Biochim Biophys Acta 1133:95-101
29. + channels in cardiac muscle. Nature 305:147-148
30. Nurko S, Sogabe K, Davis JA, Roeser NF, Defrain M, Chien A, Hinshaw D, Athey B, Meixner W, Venkatachalam MA, Weinberg JM (1996) Contribution of actin cytoskeletal alterations to ATP depletion and calcium-induced proximal tubule cell injury. Am J Physiol 270 (Renal Fluid Electrolyte Physiol 39):F39-F52
31. Panten U, Schwanstecher M, Schwanstecher C (1996) Mode of action of sulfonylureas. In: Kuhlmann J, Puls W (eds) Oral antidiabetics. Handbook of experimental pharmacology, vol 119. Springer, Berlin (in press)
32. + channel from rat liver and beef heart mitochondria. J Biol Chem 267:26062-26069
33. + channel activators, RP528912, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats. J Pharmacol Exper Ther 258:216-258
34. + channels in the kidney. Naunyn Schmiedeberg's Arch Pharmacol 354:213-225
35. Quast U (1996b) Effects of potassium channel activators in isolated blood vessels. In: Evans JM, Hamilton TC, Stemp G (eds) Potassium channels and their modulators: from synthesis to clinical experience. Taylor & Francis, London, pp 173-195
36. 3H]flunitrazepam with the benzodiazepine receptor: evidence for a ligand-induced conformation change. Biochem Pharmacol 17: 2761-2768
37. 3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers. Mol Pharmacol 43:474-481
38. - channel. Pflüger's Arch 429:659-662
39. + channel in insulin-secreting cells. J Biol Chem 262:15840-15844
40. Schwanstecher M, Löser S, Rietze I, Panten U (1991) Phosphate and thiophosphate group donating adenine and guanine nucleotides inhibit glibenclamide binding to membranes from pancreatic islets. Naunyn-Schmiedeberg's Arch Pharmacol 343:83-89
41. Schwanstecher M, Brandt C, Behrends S, Schaupp U, Panten U (1992a) Effect of MgATP on pinacidil-induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic β-cell line and rat cerebral cortex. Br J Pharmacol 106:295-301
42. Schwanstecher M, Löser S, Brandt C, Scheffer K, Rosenberger F, Panten U (1992b) Adenine nucleotide-induced inhibition of binding of sulphonylureas to their receptor in pancreatic islets. Br J Pharmacol 105:531-534
43. + channels and sulfonylurea receptors, Houston, poster 6
44. + channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents. J Gen Physiol 100:573-591
45. Tallarida RJ (1995) Receptor discrimination and control of agonist-antagonist binding. Am J Physiol 269 (Endocrinol Metab 32): E379-E391
46. Taugner R, Hackenthal E (1989) The juxtaglomerular apparatus. Springer, New York, pp 7-20
47. Trube G, Hescheler J (1984) Inward-rectifying channels in isolated patches of the heart cell membrane: ATP-dependence and comparison with cell-attached patches. Pflügers Arch 401:178-184
48. + channel activity. J Pharmacol Exp Ther 273:1382-1389
49. Wang W, Cassola A, Giebisch G (1994) Involvement of actin cytoskeleton in modulation of apical K channel activity in rat collecting duct. Am J Physiol 267 (Renal Fluid Electrolyte Physiol 36):F592-F598
50. Zini S, Ben-Ari Y, Ashford ML (1991) Characterization of sulfonylurea receptors and the action of potassium channel openers on cholinergic neurotransmission in guinea pig isolated small intestine. J Pharmacol Exp Ther 259:566-573